Literature DB >> 21407110

Decreased interleukin-10 secretion by peripheral blood mononuclear cells in children with irritable bowel syndrome.

Man-Chin Hua1, Ming-Wei Lai, Ming-Ling Kuo, Tsung-Chieh Yao, Jing-Long Huang, Shu-Mei Chen.   

Abstract

BACKGROUND AND AIMS: The aim of the present study was to evaluate proinflammatory and anti-inflammatory cytokine levels in children with irritable bowel syndrome (IBS). PATIENTS AND METHODS: Thirty-five children with IBS (17 diarrhea-predominant, 7 constipation-predominant, and 11 mixed type) and 25 healthy children as healthy controls (HCs) were enrolled. All of the participants completed a questionnaire recording the duration, severity, and associated academic and social influences. Peripheral blood mononuclear cells were isolated and cultured for 24 hours with and without 1 or 5 ng/mL Escherichia coli lipopolysaccharide (LPS). Cytokine production including tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and IL-10 was measured using enzyme-linked immunosorbent assays.
RESULTS: Children with IBS revealed lower baseline and significantly lower IL-10 levels after LPS stimulation compared with HCs (P = 0.001). Although not to a significant level, TNF-α and IL-6 levels were higher in children with IBS compared with HCs. The IL-10 levels in patients with IBS with strong pain intensity were lower both in baseline and under 1 ng/mL LPS stimulation. The levels became significantly lower under 5 ng/mL LPS stimulation compared with those experiencing mild and moderate pain intensity (P = 0.025).
CONCLUSIONS: Our study suggests that children with IBS tend to produce lower amounts of the anti-inflammatory cytokine IL-10 at baseline and after LPS stimulation, implying that defects in immune modulation may contribute to IBS in children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21407110     DOI: 10.1097/MPG.0b013e3181fd9816

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  9 in total

1.  Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome.

Authors:  Sean M P Bennet; Annikka Polster; Hans Törnblom; Stefan Isaksson; Sandrine Capronnier; Aurore Tessier; Boris Le Nevé; Magnus Simrén; Lena Öhman
Journal:  Am J Gastroenterol       Date:  2016-06-07       Impact factor: 10.864

Review 2.  Association of interleukin-10 polymorphisms with risk of irritable bowel syndrome: a meta-analysis.

Authors:  Shan-Yu Qin; Hai-Xing Jiang; Dong-Hong Lu; You Zhou
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  Serum and colonic mucosal immune markers in irritable bowel syndrome.

Authors:  Lin Chang; Mopelola Adeyemo; Iordanis Karagiannides; Iordanis Karagiannidis; Elizabeth J Videlock; Collin Bowe; Wendy Shih; Angela P Presson; Pu-Qing Yuan; Galen Cortina; Hua Gong; Sharat Singh; Arlene Licudine; Minou Mayer; Yvette Tache; Charalabos Pothoulakis; Emeran A Mayer
Journal:  Am J Gastroenterol       Date:  2011-12-13       Impact factor: 10.864

4.  Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome.

Authors:  Robert J Shulman; Monica E Jarrett; Kevin C Cain; Elizabeth K Broussard; Margaret M Heitkemper
Journal:  J Gastroenterol       Date:  2014-01-17       Impact factor: 7.527

5.  Elevated serum neopterin levels in children with functional constipation: association with systemic proinflammatory cytokines.

Authors:  Ceren Cıralı; Emel Ulusoy; Tuncay Kume; Nur Arslan
Journal:  World J Pediatr       Date:  2018-03-16       Impact factor: 2.764

6.  Pathophysiologic findings of irritable bowel syndrome in china.

Authors:  Likun Zhong; Xiaohua Hou
Journal:  J Neurogastroenterol Motil       Date:  2012-01-16       Impact factor: 4.924

Review 7.  Current insights into the innate immune system dysfunction in irritable bowel syndrome.

Authors:  Nikolaos Lazaridis; Georgios Germanidis
Journal:  Ann Gastroenterol       Date:  2018-01-18

8.  Cytokine Levels and Symptoms Among Women with Irritable Bowel Syndrome: Considering the Role of Hormonal Contraceptive Use.

Authors:  Kendra J Kamp; Claire Han; Robert J Shulman; Kevin C Cain; Pamela Barney; Mark R Opp; Lin Chang; Robert L Burr; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2020-07-17       Impact factor: 2.522

9.  Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome.

Authors:  Man-Chin Hua; Hsun-Chin Chao; Tsung-Chieh Yao; Ming-Wei Lai; Jing-Long Huang
Journal:  Gut Liver       Date:  2013-06-11       Impact factor: 4.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.